Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in GCC has been experiencing steady growth over the years. With an increasing demand for healthcare services and a growing population, the market has been able to sustain its growth.
Customer preferences: The customers in the GCC region are highly health-conscious and are willing to spend a significant amount of money on healthcare services. The demand for pharmaceuticals in the region is driven by an increasing prevalence of chronic diseases such as diabetes, hypertension, and cancer. Additionally, the customers in the region prefer branded drugs over generic drugs due to their perceived higher quality.
Trends in the market: The trend in the pharmaceutical market in the GCC region is towards the development of innovative drugs and the adoption of new technologies. The market is witnessing an increase in the number of research and development initiatives, with a focus on developing drugs for chronic diseases. Additionally, there is a growing trend towards personalized medicine, which involves the use of genetic testing to develop customized treatment plans for patients.
Local special circumstances: The GCC region has a unique healthcare system that is heavily subsidized by the government. The governments in the region provide free or highly subsidized healthcare services to their citizens, which has led to an increase in the demand for pharmaceuticals. Additionally, the region has a high prevalence of lifestyle diseases, which has further increased the demand for pharmaceuticals.
Underlying macroeconomic factors: The pharmaceutical market in the GCC region is driven by several macroeconomic factors such as the growing population, increasing healthcare expenditure, and the development of healthcare infrastructure. The region has a young and growing population with a high life expectancy, which has led to an increase in the demand for healthcare services. Additionally, the governments in the region are investing heavily in the development of healthcare infrastructure, which has further boosted the growth of the pharmaceutical market. Finally, the increasing healthcare expenditure in the region has led to an increase in the demand for pharmaceuticals.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)